Company intelligence / Profile preview

Veltera

Ownership: Private
Development stage: Other

Overview

Velsera is a global precision medicine technology company providing AI-enhanced software platforms and expert services to accelerate the discovery, development, and delivery of precision medicine. It serves biotech/pharma companies as well as clinical diagnostic labs with solutions for NGS assay implementation, reporting, validation, and large-scale multi-modal data analysis. The company claims to be one of the largest omics analytics providers in the market with active clinical NGS lab customers worldwide.

Modalities: Genomics Informatics EnablementMulti-omics Informatics EnablementNGS Assay Support
Industry: Drug Discovery Services

Partnerships

Top pharmaceutical companies (unnamed)Major researchers using Seven Bridges Platform (unnamed)

Beyond the preview

Go deeper on Veltera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Veltera.

Explore the full profile